Spinal cord injuries are among the most severe conditions affecting the nervous system and often result in permanent motor, sensory, and autonomic impairments. Despite advances in medicine, there is currently no definitive treatment capable of fully restoring function in affected patients. In most cases, available therapies are limited to reducing the extent of the damage and supporting the patient during the acute phase, while the spinal cord’s ability to regenerate spontaneously remains extremely limited. For this reason, in recent years, research has increasingly focused on regenerative medicine approaches designed to intervene more actively in the healing process by combining stem cells with innovative materials developed to support and protect them once implanted at the injury site. This thesis aims to analyse the current state of these combined strategies. It begins with an overview of the main sources of stem cells used in regenerative medicine, with particular emphasis on the stromal vascular fraction (SVF), which is especially promising because it can be obtained through relatively simple and minimally invasive procedures. The thesis then examines the biomaterials used to support these cells, particularly hydrogels, by analysing their properties, biocompatibility, and ability to act as scaffolds that promote cell adhesion and the local release of therapeutic factors directly at the injury site. The pathophysiology of spinal cord injury is subsequently discussed, distinguishing between primary and secondary damage and describing the mechanisms that make the spontaneous regeneration of nervous tissue particularly difficult. The final section is devoted to the “SpinoSave–Regenera” case study, a technology based on a patented biodegradable hydrogel capable of hosting stem cells obtained from the patient’s own adipose tissue and applied directly to the lesion during emergency surgery. The aim is therefore to provide a clear and up-to-date overview of the potential of these combined strategies, while also considering their current limitations and the challenges that must still be addressed before their widespread clinical application can become a realistic possibility.
Le lesioni al midollo spinale sono tra gli eventi più gravi che possono colpire il sistema nervoso, spesso con conseguenze permanenti sul piano motorio, sensoriale e dell’autonomia. Nonostante i progressi della medicina, ad oggi non esiste ancora una vera e propria cura in grado di restituire piena funzionalità a chi ne è colpito; infatti, i trattamenti disponibili si limitano, nella maggior parte dei casi, a contenere il danno e a supportare il paziente nella fase acuta, mentre la capacità del midollo di rigenerarsi autonomamente resta molto limitata. Per questo motivo, negli ultimi anni, la ricerca si è concentrata su approcci di medicina rigenerativa capaci di intervenire più attivamente sul processo di guarigione, combinando cellule staminali e materiali innovativi pensati per sostenerle e proteggerle una volta impiantati nella sede della lesione. Questa tesi si propone di analizzare lo stato di queste strategie combinate. Si parte dalla presentazione delle principali fonti di cellule staminali utilizzate in ambito rigenerativo, con una particolare focalizzazione sulla frazione vascolare stromale (SVF), particolarmente interessante in quanto può essere ottenuta con procedure relativamente semplici e poco invasive. Si passa, poi, ad approfondire i biomateriali impiegati come supporto per queste cellule, in particolare gli idrogeli, analizzandone le proprietà, la biocompatibilità e la capacità di fungere da impalcature per favorire l’adesione cellulare e il rilascio di fattori terapeutici direttamente nel sito di lesione. Viene poi affrontata la fisiopatologia della lesione spinale, distinguendo tra danno primario e secondario, e descrivendo i meccanismi che rendono così difficile la rigenerazione spontanea del tessuto nervoso. La parte finale, invece, è dedicata al caso studio ‘SpinoSave – Regenera’, una tecnologia che consiste in un idrogel biodegradabile brevettato, capace di ospitare cellule staminali prelevate dal tessuto adiposo dello stesso paziente e applicate direttamente sulla lesione durante l’intervento chirurgico d’urgenza. L’obiettivo è quindi offrire una panoramica chiara e aggiornata sulle potenzialità di queste strategie combinate, senza tralasciare i limiti attuali e le sfide che restano da affrontare prima di poter parlare di una reale applicazione clinica su larga scala.
Cellule Staminali e Biomateriali per la rigenerazione del midollo spinale: terapia SpinoSave - Regenera
VERNIER, CLOTILDE
2025/2026
Abstract
Spinal cord injuries are among the most severe conditions affecting the nervous system and often result in permanent motor, sensory, and autonomic impairments. Despite advances in medicine, there is currently no definitive treatment capable of fully restoring function in affected patients. In most cases, available therapies are limited to reducing the extent of the damage and supporting the patient during the acute phase, while the spinal cord’s ability to regenerate spontaneously remains extremely limited. For this reason, in recent years, research has increasingly focused on regenerative medicine approaches designed to intervene more actively in the healing process by combining stem cells with innovative materials developed to support and protect them once implanted at the injury site. This thesis aims to analyse the current state of these combined strategies. It begins with an overview of the main sources of stem cells used in regenerative medicine, with particular emphasis on the stromal vascular fraction (SVF), which is especially promising because it can be obtained through relatively simple and minimally invasive procedures. The thesis then examines the biomaterials used to support these cells, particularly hydrogels, by analysing their properties, biocompatibility, and ability to act as scaffolds that promote cell adhesion and the local release of therapeutic factors directly at the injury site. The pathophysiology of spinal cord injury is subsequently discussed, distinguishing between primary and secondary damage and describing the mechanisms that make the spontaneous regeneration of nervous tissue particularly difficult. The final section is devoted to the “SpinoSave–Regenera” case study, a technology based on a patented biodegradable hydrogel capable of hosting stem cells obtained from the patient’s own adipose tissue and applied directly to the lesion during emergency surgery. The aim is therefore to provide a clear and up-to-date overview of the potential of these combined strategies, while also considering their current limitations and the challenges that must still be addressed before their widespread clinical application can become a realistic possibility.| File | Dimensione | Formato | |
|---|---|---|---|
|
VERNIER_presentazione_prova_finale.pdf
Accesso riservato
Dimensione
2 MB
Formato
Adobe PDF
|
2 MB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/115082